학술논문 > 자연과학 > 화학
Update of early phase clinical trials in cancer immunotherapy
( Dae Ho Lee )  생화학분자생물학회(구 한국생화학분자생물학회), BMB Reports [2021] 제54권 제1호, 70~88페이지(총19페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
TAG Cancer immunotherapy, Clinical trials, Novel biomarkers, Novel therapies, Preclinical study
Genome editing of immune cells using CRISPR/Cas9
( Segi Kim ) , ( Cedric Hupperetz ) , ( Seongjoon Lim ) , ( Chan Hyuk Kim )  생화학분자생물학회(구 한국생화학분자생물학회), BMB Reports [2021] 제54권 제1호, 59~69페이지(총11페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
TAG CRISPR, Cas9, Engineered T cells, Genome editing, Genome-wide screening, HSPC engineering
Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors
( Nayoung Kim ) , ( Dong-hee Lee ) , ( Woo Seon Choi ) , ( Eunbi Yi ) , ( Hyojeong Kim ) , ( Jung Min Kim ) , ( Hyung-seung Jin ) , ( Hun Sik Kim )  생화학분자생물학회(구 한국생화학분자생물학회), BMB Reports [2021] 제54권 제1호, 44~58페이지(총15페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
TAG Cancer immunotherapy, Chimeric antigen receptors, Immune checkpoint receptors, Immune escape, Natural killer cells
The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets
( Chae Won Kim ) , ( Kyun-do Kim ) , ( Heung Kyu Lee )  생화학분자생물학회(구 한국생화학분자생물학회), BMB Reports [2021] 제54권 제1호, 31~43페이지(총13페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
TAG Cancer immunology, Cancer therapy, Dendritic cells
Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
( Ji-hae Kim ) , ( Kun-joo Lee ) , ( Seung-woo Lee )  생화학분자생물학회(구 한국생화학분자생물학회), BMB Reports [2021] 제54권 제1호, 21~30페이지(총10페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
TAG Cancer immunotherapy, Cytokine, IL-2, IL-7, T cells
Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity
( Pedram Yadollahi ) , ( You-kyoung Jeon ) , ( Wooi Loon Ng ) , ( Inhak Choi )  생화학분자생물학회(구 한국생화학분자생물학회), BMB Reports [2021] 제54권 제1호, 12~20페이지(총9페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
TAG Cancer-intrinsic PD-L1, Protumoral activity, Regulation of expression, Signaling pathway, Signalosome
Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy
( Hyung-seung Jin ) , ( Yoon Park )  생화학분자생물학회(구 한국생화학분자생물학회), BMB Reports [2021] 제54권 제1호, 2~11페이지(총10페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
TAG Cancer immunotherapy, CD112R, CD226, CD96, TIGIT
Cancer immunotherapy: special issue of BMB Reports in 2021
( Eui-cheol Shin )  생화학분자생물학회(구 한국생화학분자생물학회), BMB Reports [2021] 제54권 제1호, 1(총1페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
디젤엔진 요소수 분사 SCR 시스템에서 촉매 내 암모니아 흡장량의 증가에 따른 NOx 저감효율 향상 특성에 관한 연구
김양화 ( Kim Yanghwa ) , 임옥택 ( Lim Ockteack ) , 김홍석 ( Kim Hongsuk )  한국분무공학회, 한국분무공학회지(구 한국액체미립화학회지) [2020] 제25권 제4호, 196~203페이지(총8페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
TAG Selective catalytic reaction catalyst, 선택적 환원촉매, NOx Conversion efficiency, 질소산화물 전환효율, Ammonia adsorption, NH3 흡착, Urea water solution injection, 요소수 분사, Diesel engine, 디젤엔진
고압 인젝터의 분사율 예측을 위한 경량 모델 개발
이상권 ( Sanggwon Lee ) , 배규한 ( Gyuhan Bae ) , ( Omer Faruk Atac ) , 문석수 ( Seoksu Moon ) , 강진석 ( Jinsuk Kang )  한국분무공학회, 한국분무공학회지(구 한국액체미립화학회지) [2020] 제25권 제4호, 188~195페이지(총8페이지)
Immunotherapy has revolutionized the landscape of cancer treatment and become a standard pillar of the treatment. The two main drivers, immune checkpoint inhibitors and chimeric antigen receptor T cells, contributed to this unprecedented success. However, despite the striking clinical improvements, ...
TAG Fuel injector, 연료 인젝터, Injection rate, 분사율, Needle motion, 니들 거동, 1-D Modeling, 1-D 모델링
  1  2  3  4  5  6  7  8  9  10  
사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
copyright (c) 2009 happynlife. steel All reserved.